Dong Kim

Dong Kim

Plus aucun poste en cours
49 ans
Health Technology
Consumer Services
Commercial Services

Profil

Dong Kim formerly worked at Strides Pharma, Inc., as Director & Head-Finance from 2020 to 2021, Tharimmune, Inc., as Chief Financial Officer in 2025, Deloitte & Touche LLP, as Manager-Audit & Assurance from 2005 to 2010, Sun Pharmaceutical Industries, Inc., as Controller from 2019 to 2020, Zoetis, Inc., as Controller from 2018 to 2019, and UroGen Pharma Ltd., as Chief Financial & Accounting Officer from 2022 to 2024.
Mr. Kim received his Masters Business Admin degree from The University of North Carolina at Chapel Hill and undergraduate degree from Yonsei University.

Anciens postes connus de Dong Kim

SociétésPosteFin
CANTON STRATEGIC HOLDINGS, INC. Directeur Financier/CFO 10/06/2025
UROGEN PHARMA LTD. Directeur Financier/CFO 08/10/2024
Directeur/Membre du Conseil 01/08/2021
Comptroller/Controller/Auditor 01/04/2020
ZOETIS INC. Comptroller/Controller/Auditor 01/07/2019
Voir l'expérience en détail de Dong Kim

Formation de Dong Kim

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

84

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

🔇